-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Shanghai Henlius Biotech Says Phase 1 Clinical Trial Of Nivolumab Biosimilar HLX18 Approved By FDA

路透·12/19/2025 09:53:10

登录查看新闻详情